CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test

Cambridge, MA, USA & Rostock/Berlin, Germany, July 2, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Change in Supervisory Board

Cambridge, MA, USA & Rostock/Berlin, Germany, June 23, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

Partnership for OESIS Network

CAMBRIDGE, Mass. and SANTA MONICA, California, June 16, 2020 - In light of the current Coronavirus situation, the OESIS Network Inc and CENTOGENE, a…

Read more

CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress

Cambridge, MA, USA & Rostock/Berlin, Germany, June 15, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE to Report First-Quarter 2020 Financial Results on June 15, 2020

Cambridge, MA, USA and Rostock/Berlin, Germany, June 8, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Changes in Senior Management Team

Cambridge, MA, USA and Rostock/Berlin, Germany, May 15, 2020 (Globe Newswire) - Centogene (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Expands Senior Leadership Team with Newly Appointed Senior Vice President Communication and Marketing

Cambridge, MA, USA & Rostock/Berlin, Germany, May 6, 2020 (Globe Newswire) ─ CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Reports Financial Results for Full Year 2019 and Highlights Recent Progress

Cambridge, MA, USA & Rostock, Berlin, GERMANY, April 23, 2020 – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases…

Read more

CENTOGENE Announces Opening of Laboratory in Hamburg, Germany

Cambridge, MA, USA & Rostock/Berlin, Germany, April 15, 2020 (Globe Newswire) – CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE Smartphone App myLSDapp Now Available in Spanish

Gaucher Disease Monitoring and Treatment Management

Cambridge, MA USA & Rostock, Germany, March 24, 2020 – CENTOGENE (Nasdaq: CNTG) today announced…

Read more

For Further Inquiries Please Contact

Press Contact

Lennart Streibel

Corporate Development, IR & Communication

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads